{
    "Trade/Device Name(s)": [
        "LZI Oral Fluid Opiate Enzyme Immunoassay",
        "Calibrators and Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K050988",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981341"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "April 6, 2006",
    "Summary Letter Received Date": "March 28, 2006",
    "Submission Date": "March 24, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Drug Specific, Calibrators",
        "Single (Specified) Analyte Controls"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Morphine"
    ],
    "Specimen Type(s)": [
        "Oral fluid",
        "Saliva"
    ],
    "Specimen Container(s)": [
        "Salivette collector"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay (EIA)"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for LZI Oral Fluid Opiate Enzyme Immunoassay, calibrators and controls for qualitative detection of opiates (morphine) in human saliva using EIA technology.",
    "Indications for Use Summary": "Intended for qualitative detection of opiates in human saliva using oral fluid collected with Salivette and diluted with buffer; designed for professional use with automated clinical chemistry analyzers as a preliminary test for drugs of abuse.",
    "fda_folder": "Clinical Chemistry"
}